EWM
AGN

Endurance Wealth Management’s Allergan plc AGN Stock Holding History

Endurance Wealth Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-6,003
Closed -$1.06M – 640
2020
Q1 		$1.06M Sell
6,003
-260
-4% -$49K 0.2% 82
2019
Q4 		$1.2M Sell
6,263
-50
-0.8% -$9.02K 0.18% 89
2019
Q3 		$1.06M Sell
6,313
-175
-3% -$28.5K 0.18% 93
2019
Q2 		$1.09M Sell
6,488
-6,892
-52% -$954K 0.17% 93
2019
Q1 		$1.96M Sell
13,380
-1,514
-10% -$219K 0.32% 76
2018
Q4 		$1.99M Sell
14,894
-1,463
-9% -$240K 0.37% 69
2018
Q3 		$3.12M Buy
16,357
+100
+0.6% +$18.4K 0.49% 58
2018
Q2 		$2.71M Sell
16,257
-1,396
-8% -$224K 0.45% 58
2018
Q1 		$2.97M Sell
17,653
-714
-4% -$120K 0.5% 54
2017
Q4 		$3M Sell
18,367
-6,427
-26% -$1.15M 0.48% 57
2017
Q3 		$5.08M Sell
24,794
-724
-3% -$168K 0.84% 38
2017
Q2 		$6.2M Sell
25,518
-153
-0.6% -$36K 1.05% 33
2017
Q1 		$6.13M Buy
25,671
+456
+2% +$106K 1.06% 33
2016
Q4 		$5.29M Sell
25,215
-3,035
-11% -$629K 0.95% 35
2016
Q3 		$6.85M Sell
28,250
-191
-0.7% -$46.7K 1.23% 27
2016
Q2 		$6.57M Buy
28,441
+14,552
+105% +$3.36M 1.23% 31
2016
Q1 		$3.72K Buy
13,889
+196
+1% +$56.1K 0.52% 46
2015
Q4 		$4.28M Buy
13,693
+144
+1% +$42.9K 0.82% 40
2015
Q3 		$3.7M Sell
13,549
-2,269
-14% -$697K 0.65% 49
2015
Q2 		$4.8M Buy
15,818
+2,470
+19% +$737K 0.81% 36
2015
Q1 		$3.97M Buy
13,348
+155
+1% +$44.2K 0.69% 44
2014
Q4 		$3.4M Buy
13,193
+484
+4% +$121K 0.61% 48
2014
Q3 		$3.07M Hold
12,709
– – 0.57% 55
2014
Q2 		$2.83M Sell
12,709
-11
-0.1% -$2.28K 0.47% 59
2014
Q1 		$2.62M Buy
12,720
+300
+2% +$59.4K 0.51% 57
2013
Q4 		$2.09M Buy
+12,420
New +$1.94M 0.41% 61

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Endurance Wealth Management's AGN Position: Q2 2020 in Review

Endurance Wealth Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 6,003 shares — an estimated $1.06M sold.

Endurance Wealth Management first reported a position in AGN in Q4 2013 and held it in 26 quarters. The position peaked at $6.85M in Q3 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Endurance Wealth Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Endurance Wealth Management sold 6,003 Allergan plc shares in Q2 2020, an estimated $1.06M.
  • Endurance Wealth Management first reported a position in Allergan plc in Q4 2013 and held it in 26 quarters.
  • Endurance Wealth Management's Allergan plc position peaked at $6.85M in Q3 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Endurance Wealth Management's 13F filing for Q2 2020, filed 14 Jul 2020.